<DOC>
	<DOCNO>NCT00981227</DOCNO>
	<brief_summary>The primary objective study assess efficacy eslicarbazepine acetate ( ESL ) therapy patient post-herpetic neuralgia .</brief_summary>
	<brief_title>Efficacy Safety Eslicarbazepine Acetate Therapy Patients With Post-Herpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Eslicarbazepine acetate</mesh_term>
	<criteria>Written inform consent participate study Men woman age 18 year older Previous diagnosis herpes zoster Diagnosis postherpetic neuralgia neuropathic pain present 3 month heal herpes zoster skin rash Cooperation willingness complete aspect study Completion least 4 daily diary week precede randomisation A minimum average daily pain score 4 NRPS last 4 diary entry randomisation . Pain origin might confound assessment neuropathic pain postherpetic origin Active herpes zoster lesion dermatitis origin affect site Subjects neurological ablation block neurosurgical intervention control pain Significant unstable medical psychiatric disorder Drug alcohol abuse precede 2 year Severe renal function impairment , show calculated creatinine clearance value &lt; 30 mL/min screen Relevant clinical laboratory abnormality ( e.g. , Na+ &lt; 130 mmol/L , alanine ( ALT ) aspartate ( AST ) transaminases &gt; 2.0 time upper limit normal , white blood cell count ( WBC ) &lt; 2,500 cells/mm3 ) Previous participation study eslicarbazepine acetate Pregnancy breast feed History hypersensitivity investigational product drug similar chemical structure History noncompliance Likelihood require treatment study period drug intervention permit clinical study protocol Participation clinical study within 3 month prior screen Any clinical significant concomitant condition might influence assessment conduct trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>pain herpetic neuralgia</keyword>
</DOC>